Dr Stephen Reeders founded MVM Partners in 1997. They invest in high growth businesses with bases in London and Boston. He’s had three different lives— Firstly he obtained a BA in Natural Sciences from Cambridge, before getting his Medical Degree from Oxford and then training as a Doctor in some of the UK’s premier institutes such as John Radcliffe, Guys and Queen Square. In part II, he became a Clinical Researcher across both Oxford and some of the US’s greatest research houses. For example, just in the infancy of his career, he discovered PKD1 — a gene linked to Polycystic Kidney Disease. The seminal paper was published in Nature in 1985. Finally — in the third act, he moved into the world of business and investment — in which he tackled how to translate some of these discoveries into great businesses that could benefit people at scale. He was also the first investor and acting CEO of UpToDate. In this interview, I try and unpack what made him able to excel in all three acts — and also, why a flourishing Doctor and Clinical Academic would move into the world of investment. I hope you enjoy. You can find me on Twitter @MustafaSultan and subscribe to my newsletter on www.musty.io

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related